Daiichi Sankyo

daiichisankyo.us

Daiichi Sankyo US is a pharmaceutical company focused on innovation in cancer treatment and other diseases. With over 120 years of heritage, the company is dedicated to transforming how diseases are treated, particularly through its HER2 directed antibody drug conjugate (ADC) which has received industry recognition. The company emphasizes patient-centric approaches and has a robust pipeline of innovative medicines, positioning itself strongly in the healthcare market.